CN100398128C - Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture - Google Patents
Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture Download PDFInfo
- Publication number
- CN100398128C CN100398128C CNB2006100079339A CN200610007933A CN100398128C CN 100398128 C CN100398128 C CN 100398128C CN B2006100079339 A CNB2006100079339 A CN B2006100079339A CN 200610007933 A CN200610007933 A CN 200610007933A CN 100398128 C CN100398128 C CN 100398128C
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- portions
- fracture
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 208000010392 Bone Fractures Diseases 0.000 title claims abstract description 14
- 208000025962 Crush injury Diseases 0.000 title abstract 4
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title abstract 4
- 208000029761 vertebral disease Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title description 2
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 24
- 241001057584 Myrrha Species 0.000 claims description 13
- 239000009286 sanguis draxonis Substances 0.000 claims description 12
- 208000012287 Prolapse Diseases 0.000 claims description 11
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 11
- 208000036319 cervical spondylosis Diseases 0.000 claims description 11
- 208000005801 spondylosis Diseases 0.000 claims description 11
- 206010017076 Fracture Diseases 0.000 claims description 10
- 208000024779 Comminuted Fractures Diseases 0.000 claims description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 6
- 244000235603 Acacia catechu Species 0.000 claims description 6
- 241000208340 Araliaceae Species 0.000 claims description 6
- 235000006226 Areca catechu Nutrition 0.000 claims description 6
- 241000190633 Cordyceps Species 0.000 claims description 6
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 201000005671 spondyloarthropathy Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 16
- 239000006187 pill Substances 0.000 description 7
- 238000000227 grinding Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicament for treating cervical vertebra diseases, lumbar intervertebral disk protrusion, bone fracture and crush fracture, which mainly solves the problems of difficult therapy of the existing cervical spondylopathy, lumbar intervertebral disk protrusion, bone fracture and crush fracture, and is characterized in that the medicament is prepared from 1 to 1.5 portions by weight of angelica, 1 to 1.5 portions by weight of myrrh, 0.5 to 1 portion by weight of aweto, 1 to 1.4 portions by weight of prepared rhizome of rehmannia, 1.5 to 2 portions by weight of dragon blood, 1 to 1.5 portions by weight of tuckaho, 1 to 1.5 portions by weight of white peony root , 1 to 1.5 portions by weight of clove, 1 to 1.5 portions by weight of acanthopanax bark, 1.5 to 2 portions by weight of ginseng, 1 to 1.5 portions by weight of dried old orange peel, 1 to 1.5 portions by weight of safflower, 1 to 1.5 portions by weight of olibanum, 1 to 1.5 portions by weight of hemlock parsley and 1 to 1.5 portions by weight of cortex moutan. The medicament has the characteristics of short course of treatment, obvious effect and high treatment rate to cervical vertebra diseases, lumbar intervertebral disk protrusion, bone fracture and crush fracture.
Description
Technical field:
The present invention relates to the used a kind of pharmaceutical composition of medical technical field, belong to a kind of medicine for the treatment of cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture.
Background technology:
Cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture are commonly encountered diseases, stubborn disease, the medicine of treatment cervical spondylosis and prolapse of lumbar intervertebral disc has varied at present, Chinese medicine, Western medicine, for oral administration or external are arranged, but in clinical DeGrain, cure rate is extremely low; Equally, the medicine for the treatment of cervical spondylosis and prolapse of lumbar intervertebral disc at present has varied, and Chinese medicine, Western medicine, for oral administration or external are arranged, and the overwhelming majority will undergo surgery in clinical, and effect of drugs is not clearly, and misery is very big concerning the patient.
Summary of the invention:
Cure difficult problem in order to solve existing cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture, the invention provides a kind of pharmaceutical composition, this pharmaceutical composition has short treating period, instant effect, characteristics that cure rate is high to cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture.
The technical solution adopted in the present invention is: the medicine of this treatment cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture is made up of following component, the following components by weight parts proportioning:
A: 1 part～1.5 parts of Radix Angelicae Sinensis, 1 part～1.5 parts of Myrrhas, 0.5 part～1 part of Cordyceps, 1 part～1.5 parts in Radix Rehmanniae Preparata, 1.5 parts～2 parts of Sanguis Draxonis, 1 part～1.5 parts in Poria, 1 part～1.5 parts of the Radix Paeoniae Albas, 1 part～1.5 parts of Flos Caryophyllis, 1 part～1.5 parts of Cortex Acanthopanacis Radicis, 1.5 parts～2 parts of Radix Ginsengs, 1 part～1.5 parts of Pericarpium Citri Reticulataes, 1 part～1.5 parts on Flos Carthami, 1 part～1.5 parts of Olibanums, 1 part～1.5 parts of Rhizoma Chuanxiongs, 1 part～1.5 parts of Cortex Moutans; B: 1 part～1.5 parts of Lignum Sappans, 2 parts～3 parts on Flos Carthami, 0.2 part～0.5 part in Moschus, 1 part～2 parts of Olibanums, 1 part～1.5 parts of Flos Caryophyllis,
1 part～1.5 parts of 1 part～1.5 parts of worms, 1 part～2 parts of Myrrhas, 1 part～2 parts of Radix Dipsacis, 1 part～1.5 parts of Radix Notoginseng, 2 parts～3 parts of Sanguis Draxonis and Catechu.
The invention has the beneficial effects as follows: the medicament that adopts such scheme to be mixed with, this medicament has the effect of promoting blood circulation to remove obstruction in the collateral, enriching yin and nourishing kidney, expelling wind and cold, strengthening the tendons and bones, best to lumbago and skelalgia curative effect of disease such as cervical spondylosis, prolapse of lumbar intervertebral disc, hyperosteogeny and lumbar muscle strains, the lighter cures a course of treatment substantially, and severe patient 2-3 cures a course of treatment substantially; Various types of contusion, fracture, bone does not connect there is specially good effect, to general fracture, reset after, 3-4 can reach clinical cure about week, to comminuted fracture, after resetting or after resetting substantially, 6-8 can reach clinical cure about week, and has short treating period, cure rate height, characteristics easy to use.
Following table is these clinical drug experiment statistics data:
Table 1
The specific embodiment:
Below with the invention will be further described:
The medicine of this treatment cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture, it is characterized in that: form following components by weight parts proportioning: A group: 1 part～1.5 parts of Radix Angelicae Sinensis, 1 part～1.5 parts of Myrrhas, 0.5 part～1 part of Cordyceps, 1 part～1.5 parts in Radix Rehmanniae Preparata, 1.5 parts～2 parts of Sanguis Draxonis, 1 part～1.5 parts in Poria, 1 part～1.5 parts of the Radix Paeoniae Albas, 1 part～1.5 parts of Flos Caryophyllis, 1 part～1.5 parts of Cortex Acanthopanacis Radicis, 1.5 parts～2 parts of Radix Ginsengs, 1 part～1.5 parts of Pericarpium Citri Reticulataes, 1 part～1.5 parts on Flos Carthami, 1 part～1.5 parts of Olibanums, 1 part～1.5 parts of Rhizoma Chuanxiongs, 1 part～1.5 parts of Cortex Moutans by following component; B group: 1 part～1.5 parts of Lignum Sappans, 2 parts～3 parts on Flos Carthami, 0.2 part～0.5 part in Moschus, 1 part～2 parts of Olibanums, 1 part～1.5 parts of Flos Caryophyllis,
1 part～1.5 parts of 1 part～1.5 parts of worms, 1 part～2 parts of Myrrhas, 1 part～2 parts of Radix Dipsacis, 1 part～1.5 parts of Radix Notoginseng, 2 parts～3 parts of Sanguis Draxonis and Catechu.
Organize the A in said medicine group and B respectively that powder is a smalls, be processed into the watered pill of different colours.Wherein Radix Angelicae Sinensis, the Radix Paeoniae Alba, Olibanum and Myrrha needed wine to process before powder.
The usage and dosage of this medicine: take medicine every day three times, consumption 9 grams are obeyed the A group sooner or later, obey the B group noon.
Embodiment 1, to become smalls to make the watered pill 1 part of Radix Angelicae Sinensis (needing wine to process), 1.2 parts of Myrrhas (needing wine to process), 1 part of Cordyceps, 1 part in Radix Rehmanniae Preparata, 1.7 parts of Sanguis Draxonis, 1.5 parts in Poria, 1 part of the Radix Paeoniae Alba (needing wine to process), 1.3 parts of Flos Caryophyllis, 1.5 parts of Cortex Acanthopanacis Radicis, 1.5 parts of Radix Ginsengs, 1.2 parts of Pericarpium Citri Reticulataes, 1.5 parts on Flos Carthami, 1 part of Olibanum (needing wine to process), 1.3 parts of Rhizoma Chuanxiongs and 1.5 parts of mixed grindings of Cortex Moutan be A group; With 1 part of Lignum Sappan, 2.5 parts on Flos Carthami, 0.5 part in Moschus, 1 part of Olibanum, 1.2 parts of Flos Caryophyllis,
It is the B group that 1.5 parts of worms, 1 part of Myrrha (needing wine to process), 1.5 parts of Radix Dipsacis, 1.5 parts of Radix Notoginseng, 2 parts of Sanguis Draxonis and 1.3 parts of mixed grindings of Catechu become smalls to make the watered pill.
Embodiment 2, to become smalls to make the watered pill 1.2 parts of Radix Angelicae Sinensis (needing wine to process), 1.5 parts of Myrrhas (needing wine to process), 0.5 part of Cordyceps, Radix Rehmanniae Preparata .1.2 part, 2 parts of Sanguis Draxonis, 1 part in Poria, 1.2 parts of the Radix Paeoniae Albas (needing wine to process), 1.5 parts of Flos Caryophyllis, 1 part of Cortex Acanthopanacis Radicis, 1.7 parts of Radix Ginsengs, 1.5 parts of Pericarpium Citri Reticulataes, 1 part on Flos Carthami, 1.2 parts of Olibanums (needing wine to process), 1.5 parts of Rhizoma Chuanxiongs and 1 part of mixed grinding of Cortex Moutan be A group; With 1.2 parts of Lignum Sappans, 3 parts on Flos Carthami, 0.2 part in Moschus, 1.5 parts of Olibanums, 1.5 parts of Flos Caryophyllis,
It is the B group that 1 part of worm, 1.5 parts of Myrrhas (needing wine to process), 2 parts of Radix Dipsacis, 1 part of Radix Notoginseng, 2.5 parts of Sanguis Draxonis and 1.5 parts of mixed grindings of Catechu become smalls to make the watered pill.
Embodiment 3, to become smalls to make the watered pill 1.5 parts of Radix Angelicae Sinensis (needing wine to process), 1 part of Myrrha (needing wine to process), 0.7 part of Cordyceps, 1.5 parts in Radix Rehmanniae Preparata, 1.5 parts of Sanguis Draxonis, 1.2 parts in Poria, 1.5 parts of the Radix Paeoniae Albas (needing wine to process), 1 part of Flos Caryophylli, 1.2 parts of Cortex Acanthopanacis Radicis, 2 parts of Radix Ginsengs, 1 part of Pericarpium Citri Reticulatae, 1.2 parts on Flos Carthami, 1.5 parts of Olibanums (needing wine to process), 1 part of Rhizoma Chuanxiong and 1.2 parts of mixed grindings of Cortex Moutan be A group; With 1.5 parts of Lignum Sappans, 2 parts on Flos Carthami, 0.3 part in Moschus, 2 parts of Olibanums, 1 part of Flos Caryophylli,
It is the B group that 1.2 parts of worms, 2 parts of Myrrhas (needing wine to process), 1 part of Radix Dipsaci, 1.2 parts of Radix Notoginseng, 3 parts of Sanguis Draxonis and 1 part of mixed grinding of Catechu become smalls to make the watered pill.
Claims (1)
1. medicine for the treatment of cervical spondylosis, prolapse of lumbar intervertebral disc, fracture and comminuted fracture is characterized in that: be made of the following components by weight parts proportioning following component:
The A group: wine is processed 1 part～1.5 parts of Radix Angelicae Sinensis, 1 part～1.5 parts of wine Myrrha (processed)s, 0.5 part～1 part of Cordyceps, 1 part～1.5 parts in Radix Rehmanniae Preparata, 1.5 parts～2 parts of Sanguis Draxonis, 1 part～1.5 parts in Poria, 1 part～1.5 parts of Radix Paeoniae Alba (processed with wine), 1 part～1.5 parts of Flos Caryophyllis, 1 part～1.5 parts of Cortex Acanthopanacis Radicis, 1.5 parts～2 parts of Radix Ginsengs, 1 part～1.5 parts of Pericarpium Citri Reticulataes, 1 part～1.5 parts on Flos Carthami, 1 part～1.5 parts of wine Olibanum (processed), 1 part～1.5 parts of Rhizoma Chuanxiongs, 1 part～1.5 parts of Cortex Moutans;
B group: 1 part～1.5 parts of Lignum Sappans, 2 parts～3 parts on Flos Carthami, 0.2 part～0.5 part in Moschus, 1 part～2 parts of Olibanums, 1 part～1.5 parts of Flos Caryophyllis,
1 part～1.5 parts of 1 part～1.5 parts of worms, 1 part～2 parts of wine Myrrha (processed)s, 1 part～2 parts of Radix Dipsacis, 1 part～1.5 parts of Radix Notoginseng, 2 parts～3 parts of Sanguis Draxonis and Catechu.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100079339A CN100398128C (en) | 2006-02-23 | 2006-02-23 | Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100079339A CN100398128C (en) | 2006-02-23 | 2006-02-23 | Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1843444A CN1843444A (en) | 2006-10-11 |
| CN100398128C true CN100398128C (en) | 2008-07-02 |
Family
ID=37062430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100079339A Expired - Fee Related CN100398128C (en) | 2006-02-23 | 2006-02-23 | Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100398128C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313111A (en) * | 2000-03-15 | 2001-09-19 | 蒲荣 | Health-care medical wine for invigorating function of kidney and strengthening bone |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
-
2006
- 2006-02-23 CN CNB2006100079339A patent/CN100398128C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313111A (en) * | 2000-03-15 | 2001-09-19 | 蒲荣 | Health-care medical wine for invigorating function of kidney and strengthening bone |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1843444A (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103933353A (en) | Medicament for treating rheumatism and gout | |
| CN102526691A (en) | External application plaster for treating dysmenorrhea | |
| CN104337974A (en) | Drug for treating metrorrhagia and preparation method thereof | |
| CN105169076A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN102008551B (en) | Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN101284084A (en) | Externally used Chinese medicine for curing hyperosteogeny and protrusion of lumbar intervertebral discs | |
| CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN100398128C (en) | Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture | |
| CN103100010A (en) | Drug for treatment of rheumatic arthritis | |
| CN103463460A (en) | Oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine for treating various types of rhinitis | |
| CN101837111A (en) | Medicament for curing proliferation of mammary glands and preparation method thereof | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN101732628A (en) | Chinese medicament for treating intestinal obstruction | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN1175875C (en) | Medicine made of lysimachia for treating hepatobiliary calculus and its prescription | |
| CN103356963B (en) | Traditional Chinese medicine composition for treating infertility | |
| CN106620531A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090123 Address after: Daqing hi tech Development Zone, Jianshe Road, 245, post code: 163316 Patentee after: Zhao Yanyi Address before: Three village, Changchun Ling, Changchun village, Bayan County, Heilongjiang Province, zip code: 151808 Co-patentee before: Huo Jichen Patentee before: Ho Xiang - I Co-patentee before: Li Dongmei Co-patentee before: Huo Xiangxuan |
|
| ASS | Succession or assignment of patent right |
Owner name: ZHAO YANYI Free format text: FORMER OWNER: HUO XIANGKUI Effective date: 20090123 |
|
| ASS | Succession or assignment of patent right |
Owner name: HEILONGJIANG TIANYI PHARMACEUTICAL CO., LTD Free format text: FORMER OWNER: ZHAO YANYI Effective date: 20101009 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 163316 NO.245, JIANSHE ROAD, HIGH-TECH. ZONE, DAQING TO: 163316 NO.245, JIANSHE ROAD, HIGH-TECH. ZONE, DAQING CITY, HEILONGJIANG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20101009 Address after: 163316 Jianshe Road high tech Zone, Heilongjiang, No. 245, Patentee after: Heilongjiang Tianyi Pharmaceutical Co., Ltd. Address before: 163316 Daqing hi tech Development Zone, Jianshe Road 245 Patentee before: Zhao Yanyi |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160629 Address after: 151808 Bayan village, Changchun County, Heilongjiang Province, Changchun village, three Tuen Mun Patentee after: Huo Xiangkui Patentee after: Huo Jichen Address before: 163316 Jianshe Road high tech Zone, Heilongjiang, No. 245, Patentee before: Heilongjiang Tianyi Pharmaceutical Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080702 Termination date: 20170223 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |